
The 'Fleeting' DNA Mark That Could Revolutionise Cancer Care
Once dismissed as a temporary intermediate in DNA maintenance, 5-hydroxymethylcytosine (5hmC) is now recognised as a crucial regulator of gene expression. New research highlights its potential as a powerful biomarker for cancer detection and a key factor in determining how tumours respond to chemotherapy.
By Kharat, Sharan

